Day One Biopharmaceuticals, Inc.
DAWNDelisted Apr 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001845337
Day One Biopharmaceuticals, Inc. was delisted on Apr 23, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Day One Biopharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 157 | 2 | 166 | +11 |
| Shares | 74.7M | 4.53M | 92.1M | +21.9M (+31.1%) |
| Value | $1.03B | $62.5M | $1.28B | +$316.3M (+32.7%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (34)
Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (23)
Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Ally Bridge Group (NY) LLC | 536,095 | $7.39M |
| Point72 Asset Management, L.P. | 470,247 | $6.48M |
| Monashee Investment Management LLC | 200,000 | $2.76M |
| Squarepoint Ops LLC | 186,484 | $2.57M |
| Laurion Capital Management LP | 171,887 | $2.37M |
| Marshall Wace, LLP | 161,129 | $2.22M |
| HRT Financial LP | 98,624 | $1.36M |
| J. Goldman & Co LP | 44,943 | $619.3K |
| Prudential Financial Inc | 22,592 | $311.3K |
| ExodusPoint Capital Management, LP | 14,873 | $205.0K |
| Aigen Investment Management, LP | 14,008 | $193.0K |
| Y-Intercept (Hong Kong) Ltd | 13,822 | $190.5K |
| Torno Capital, LLC | 13,037 | $179.7K |
| HSBC Holdings PLC | 11,658 | $162.5K |
| Centiva Capital, LP | 10,366 | $142.8K |
| Paloma Partners Management Co | 10,000 | $137.8K |
| Regency Capital Management Inc. | 10,000 | $137.8K |
| SG Americas Securities, LLC | 8,222 | $113.0K |
| Group One Trading, L.P. | 5,987 | $82.5K |
| Catalyst Funds Management Pty Ltd | 1,200 | $16.5K |
| Pacer Advisors, Inc. | 851 | $11.7K |
| CarsonAllaria Wealth Management, Ltd. | 180 | $2.48K |
| Smartleaf Asset Management LLC | 19 | $262 |
Not filed for Q3 2024 yet (2)
Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 4,533,442 | $62.5M |
| ICA Group Wealth Management, LLC | 490 | $6.75K |